Off-label use and the spectre of drug-eluting stent thrombosis.
作者信息
Cook Stéphane, Wenaweser Peter
出版信息
Circ Cardiovasc Interv. 2009 Aug;2(4):273-6. doi: 10.1161/CIRCINTERVENTIONS.109.891218.
Abstract
摘要
相似文献
1
Off-label use and the spectre of drug-eluting stent thrombosis.非标签使用与药物洗脱支架血栓形成的幽灵
Circ Cardiovasc Interv. 2009 Aug;2(4):273-6. doi: 10.1161/CIRCINTERVENTIONS.109.891218.
2
Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.常规临床实践中的药物洗脱支架血栓形成：来自 TAXUS ARRIVE 注册研究的两年结果和预测因素。
Circ Cardiovasc Interv. 2009 Aug;2(4):285-93. doi: 10.1161/CIRCINTERVENTIONS.109.852178.109.852178. Epub 2009 Jul 22.
3
Stenting unprotected left main: the outcome is not always favorable.对无保护左主干进行支架置入术：结果并非总是良好。
Catheter Cardiovasc Interv. 2008 Mar 1;71(4):539-40. doi: 10.1002/ccd.21536.
4
Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading?
Catheter Cardiovasc Interv. 2010 Jul 1;76(1):58-9. doi: 10.1002/ccd.22678.
5
Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.经皮冠状动脉介入治疗的最新进展：药物洗脱支架的演变，聚焦于XIENCE V药物洗脱支架。
Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550.
6
Are we totally clear?
Catheter Cardiovasc Interv. 2009 Dec 1;74(7):987-8. doi: 10.1002/ccd.22335.
7
Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry.
Catheter Cardiovasc Interv. 2008 Oct 1;72(4):433-45. doi: 10.1002/ccd.21618.
8
Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".急性心肌梗死期间“非保护”左主干的经皮血管重建：“敢于斗争！敢于胜利！”
Catheter Cardiovasc Interv. 2009 Jan 1;73(1):22-4. doi: 10.1002/ccd.21909.
9
Clopidogrel use in diabetic patients with new stents.氯吡格雷在置入新支架的糖尿病患者中的应用。
Cardiovasc J Afr. 2008 Jul-Aug;19(4):232.
10
SES for AMI: moving in the right direction.急性心肌梗死的药物洗脱支架：朝着正确的方向发展。
Catheter Cardiovasc Interv. 2009 Aug 1;74(2):333-4. doi: 10.1002/ccd.22185.
引用本文的文献
1
Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents.使用依次释放乙酰水杨酸和载有紫杉醇的可生物降解支架促进内皮恢复并减少新生内膜增生。
Int J Nanomedicine. 2014 Aug 27;9:4117-33. doi: 10.2147/IJN.S67721. eCollection 2014.
Zotero 插件